List of insiders holdings for HTG MOLECULAR DIAGNOSTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | QIAGEN NV 10% Owner | 2017-11-07 19:32:55 | 1,586,345 0 | 1,586,345 | Form 13G |
| 2 | L5 Capital Inc. 10% Owner | 2022-07-18 09:00:09 | 1,170,000 0 | 1,170,000 | Form 3 |
| 3 | GLAXOSMITHKLINE PLC Former 10% Owner | 2018-02-13 16:36:48 | 792,781 0 | 792,781 | Form 13D |
| 4 | Fletcher Spaght Ventures II LP FSV II LP FSV II-B LP 10% Owner | 2015-05-13 16:20:26 | 0 652,546 | 652,546 | Form 4 |
| 5 | Gordon Debra A SVP, Chief Legal Counsel | 2018-01-31 16:57:06 | 72,552 0 | 72,552 | Form 4 |
| 6 | Novo Holdings A/S 10% Owner | 2017-08-29 16:29:33 | 49,786 0 | 49,786 | Form 13D |
| 7 | Roche Patrick C. SVP Medical/Scientific Affairs | 2018-06-14 18:46:35 | 44,209 0 | 44,209 | Form 4 |
| 8 | JOHNSON TIM B Executive Chairman | 2021-01-04 17:53:47 | 16,738 0 | 16,738 | Form 4 |
| 9 | Lubniewski John L President & CEO | 2022-12-13 17:40:18 | 14,133 0 | 14,133 | Form 4 |
| 10 | McMeans Shaun D SVP, Finance & Admin. & CFO | 2022-12-13 17:39:26 | 10,570 0 | 10,570 | Form 4 |
| 11 | HANHAM ANN Director | 2022-09-15 18:05:32 | 8,000 0 | 8,000 | Form 4 |
| 12 | Dubensky Thomas W. Director | 2022-08-22 17:27:24 | 8,000 0 | 8,000 | Form 4 |
| 13 | Lawson Byron SVP/Chief Commercial Officer | 2022-12-13 17:41:03 | 6,033 0 | 6,033 | Form 4 |
| 14 | Shuster Lewis Director | 2017-08-16 16:33:58 | 6,000 0 | 6,000 | Form 4 |
| 15 | GRIMM DONALD W Director | 2015-05-13 16:28:13 | 5,000 0 | 5,000 | Form 4 |
| 16 | Godlewski Laura Lee SVP Finance & Administration | 2022-12-13 17:38:34 | 4,904 0 | 4,904 | Form 4 |
| 17 | George Harry A. Director | 2021-08-19 17:12:27 | 4,000 0 | 4,000 | Form 4 |
| 18 | LAFRANCE JAMES T Director | 2021-08-19 17:17:17 | 4,000 0 | 4,000 | Form 4 |
| 19 | HARDISON DON M Director | 2022-09-15 18:08:44 | 4,000 0 | 4,000 | Form 4 |
| 20 | McCracken Lee R. Director | 2022-09-15 18:11:10 | 4,000 0 | 4,000 | Form 4 |
| 21 | GRIFFIN MICHELLE RENEE Director | 2022-09-15 18:12:42 | 4,000 0 | 4,000 | Form 4 |
| 22 | KIRITSY CHRISTOPHER P Director | 2022-09-15 18:15:11 | 4,000 0 | 4,000 | Form 4 |
| 23 | Barat Stephen Senior VP of Therapeutics | 2023-06-09 20:11:23 | 421 0 | 421 | Form 4 |
| 24 | LYTTON LAURENCE W 10% Owner | 2023-02-13 15:33:23 | 0 0 | 0 | Form 13G |
| 25 | Merck Capital Ventures LLC Senour Lawrence D. 10% Owner | 2019-02-14 14:09:11 | 0 0 | 0 | Form 13G |
| 26 | Hoult Mary Director | 2015-05-05 18:07:54 | 0 0 | 0 | Form 3 |
| 27 | George Simeon Director | 2015-05-05 18:02:14 | 0 0 | 0 | Form 3 |
| 28 | Bisgaard Peter Director | 2015-05-05 17:52:12 | 0 0 | 0 | Form 3 |